Skip to main content

Published locations for IL-6 inhibitor tocilizumab proved effective in severe, refractory JIA

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. IL-6 inhibitor tocilizumab proved effective in severe, refractory JIA

User login

  • Reset your password
  • /content/il-6-inhibitor-tocilizumab-proved-effective-severe-refractory-jia
  • /pediatricnews/article/57082/pediatrics/il-6-inhibitor-tocilizumab-proved-effective-severe-refractory
  • /rheumatologynews/article/57082/pediatrics/il-6-inhibitor-tocilizumab-proved-effective-severe
  • /pediatrics/article/57082/pediatrics/il-6-inhibitor-tocilizumab-proved-effective-severe-refractory
  • /rheumatology/article/57082/pediatrics/il-6-inhibitor-tocilizumab-proved-effective-severe-refractory